FDA Inspection
Eurofins Lancaster Laboratories, IncEurofins Lancaster Laboratories, Inc – FDA Inspection, Sep 23, 2025
Record Details
This FDA Inspection record concerns Eurofins Lancaster Laboratories, Inc, with an inspection on September 23, 2025, issued by the Philadelphia District Office, covering biologics.
- Person
View Company Profile
ID · d905bc5d-0d6c-4d5e-b731-266193c1d3d1
Inspection Facts
- Inspection number
- 1284580
- FDA center
- Biologics
Other FDA inspections of Eurofins Lancaster Laboratories, Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2025 | VAI | Philadelphia District Office | Drug Quality Assurance |
| October 21, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 17, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 13, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 19, 2017 | Not classified | Philadelphia District Office |
Other documents for Eurofins Lancaster Laboratories, Inc
- FDA Inspection 1279557 - 2025-08-26
- FDA Inspection 1156933 - 2021-10-21
- FDA Inspection 1113269 - 2019-10-17
- FDA Inspection 1106449 - 2019-09-13
- FDA Inspection 1031761 - 2017-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.